Nyxoah S.A. (EBR:NYXH)
Belgium
· Delayed Price · Currency is EUR 6.68
-0.40 (-5.65%)
Last updated: Mar 31, 2025
Nyxoah Revenue
In the year 2024, Nyxoah had annual revenue of 4.52M EUR with 3.98% growth. Nyxoah had revenue of 1.26M in the quarter ending December 31, 2024, a decrease of -30.76%.
Revenue
4.52M
Revenue Growth
+3.98%
P/S Ratio
51.28
Revenue / Employee
24.57K
Employees
184
Market Cap
264.99M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| argenx SE | 2.17B |
| UCB SA | 6.15B |
| Financière de Tubize | 13.26K |
| Fagron NV | 871.96M |
| Ion Beam Applications | 465.75M |
| Onward Medical | -188.00K |
| Hyloris Pharmaceuticals | 10.04M |
| Sequana Medical NV | 433.50K |